GlassScriptPhysician profile
Ghassan G Sinada
NPI 1043378169
$1,593.94
in general payments reported to CMS, 2019-2025
10 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.43 · 2020: $477 · 2021: $4.49 · 2022: $536 · 2023: $73.87 · 2024: $216 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Longeviti Neuro Solutions INC | $775.04 | 2020-2025 | Clearfit |
| A-Dec, INC. | $185.52 | 2020 | |
| Ultradent Products INC | $183.88 | 2022 | |
| Straumann USA LLC | $138.35 | 2022-2023 | |
| Zimvie INC. | $118.73 | 2022-2025 | |
| Nobel Biocare USA | $86.43 | 2019 | |
| Kls-Martin L.P. | $75.49 | 2024 | |
| Dentsply Sirona INC | $13.51 | 2023 | Implant Dentistry |
| Philips North America LLC | $12.50 | 2020 | |
| Ace Surgical Supply Co., INC. | $4.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$18,104,455.83 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghassan Sinada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.